Goldman Sachs Upgrades Krystal Biotech (KRYS) to Buy
Tweet Send to a Friend
(Updated - February 28, 2023 3:59 AM EST)
Goldman Sachs analyst Madhu Kumar upgraded Krystal Biotech (NASDAQ: KRYS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Madhu Kumar upgraded Krystal Biotech (NASDAQ: KRYS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
